ロード中...

Overexpression of eis without a mutation in promoter region of amikacin- and kanamycin-resistant Mycobacterium tuberculosis clinical strain

BACKGROUND: Aminoglycosides such as amikacin and kanamycin are effective injectable second-line drugs for treatment of multidrug-resistant tuberculosis. Molecular mechanisms underlying aminoglycoside resistance are not well understood. We have previously identified the amikacin- and kanamycin-resist...

詳細記述

保存先:
書誌詳細
出版年:Ann Clin Microbiol Antimicrob
主要な著者: Sowajassatakul, Angkanang, Prammananan, Therdsak, Chaiprasert, Angkana, Phunpruch, Saranya
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6047124/
https://ncbi.nlm.nih.gov/pubmed/30008266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12941-018-0285-6
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!